NCT03798067

Brief Summary

Acute kidney injury (AKI) is a common complication of cardiac surgery, which seriously affects the postoperative complication rate and mortality of patients.Acute kidney injury occurs in 5-30% of patients after cardiac surgery, but severe acute kidney injury requiring dialysis is relatively rare.At present, the diagnosis of AKI is based on serum creatinine (Scr) or urine volume. However, the changes of serum creatinine value have hysteresis, and the increase of serum creatinine level lags behind kidney injury for 48 \~ 72 h.Some drugs can also affect creatinine levels.Urine volume is also affected by many factors.Due to the lack of sensitivity and specificity of SCr, it is very important to find and adopt new early AKI markers.Kidney is an important metabolic organ of human body. Different from cerebrovascular system, kidney lacks automatic regulation ability and is easily affected by perfusion flow.Previous experiments have shown that placing a multi-plane esophageal probe into the human stomach through the esophagus can monitor the changes of left renal blood flow before, during and after cardiovascular surgery extracorporeal circulation, and has good repeatability, which may become an effective means to monitor renal blood flow during cardiovascular surgery. In conclusion, this study intends to use esophageal ultrasound as a means to monitor renal blood flow, observe the changes of intraoperative renal hemodynamic indexes, and use KDIGO ( Kidney Disease:Improving Global Outcomes)as the standard of renal injury to explore the correlation between intraoperative hemodynamic changes and postoperative AKI, providing a new perspective for the pathophysiological study of AKI after cardiopulmonary bypass.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2019

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 1, 2019

Completed
1 day until next milestone

Study Start

First participant enrolled

January 2, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 9, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2019

Completed
Last Updated

January 9, 2019

Status Verified

December 1, 2018

Enrollment Period

8 months

First QC Date

January 1, 2019

Last Update Submit

January 4, 2019

Conditions

Outcome Measures

Primary Outcomes (2)

  • AUC(RI)

    ROC curve(receiver operating characteristic curve)will be drawn according to the incidence of renal resistance index (RI) monitored by TEE and the incidence of postoperative AKI in patients, and AUC value(Area Under Curve) will be statistically analyzed.

    RI monitored 30 minutes after cardiopulmonary bypass termination

  • AUC(PI)

    ROC curve will be drawn according to the incidence of renal pulsatility index (PI) monitored by TEE and the incidence of postoperative AKI in patients, and AUC value will be statistically analyzed.

    PI monitored 30 minutes after cardiopulmonary bypass termination

Secondary Outcomes (5)

  • Changes in biomarkers

    Before surgery and at 4 hours, 12 hours, and 24 hours after surgery

  • Length of ICU stay

    an average of 2 days

  • Length of hospital stay

    an average of 10 days

  • Use of renal replacement therapy

    Until 3 months after discharge

  • Survival rate

    At 1, 7 and 30 days after discharge

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

60 patients undergoing elective cardiac surgery in the Affiliated Hospital of Xuzhou Medical University.

You may qualify if:

  • Aged between 18 and 70;
  • Elective cardiopulmonary bypass for patients undergoing cardiac surgery

You may not qualify if:

  • Acute myocardial infarction surgery within 7 days
  • Emergency surgery
  • Known renal artery stenosis, renal malformation;Renal failure
  • Congenital esophageal malformation
  • Patients with previous history of stomach and esophagus should avoid intraoperative esophageal ultrasound examination
  • Existing acute kidney injury, kidney transplantation, chronic kidney disease and glomerular filtration rate less than 30 ml/min,
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (4)

  • Weisse AB. Cardiac surgery: a century of progress. Tex Heart Inst J. 2011;38(5):486-90.

  • Wang Y, Bellomo R. Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment. Nat Rev Nephrol. 2017 Nov;13(11):697-711. doi: 10.1038/nrneph.2017.119. Epub 2017 Sep 4.

  • Bellos I, Pergialiotis V, Kontzoglou K. Renal resistive index as predictor of acute kidney injury after major surgery: A systematic review and meta-analysis. J Crit Care. 2019 Apr;50:36-43. doi: 10.1016/j.jcrc.2018.11.001. Epub 2018 Nov 15.

  • Regolisti G, Maggiore U, Cademartiri C, Belli L, Gherli T, Cabassi A, Morabito S, Castellano G, Gesualdo L, Fiaccadori E. Renal resistive index by transesophageal and transparietal echo-doppler imaging for the prediction of acute kidney injury in patients undergoing major heart surgery. J Nephrol. 2017 Apr;30(2):243-253. doi: 10.1007/s40620-016-0289-2. Epub 2016 Mar 19.

Biospecimen

Retention: SAMPLES WITH DNA

Creatinine, eGFR: blood was collected preoperatively, 4h postoperatively, and at least 3 days postoperatively in the morning. TIMP-2,IGPBP-7:Urine samples were collected before and after surgery at 4, 12 and 24 hours

Study Officials

  • Jin Dong Liu, M.S

    The Affiliated Hospital of Xuzhou Medical University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 1, 2019

First Posted

January 9, 2019

Study Start

January 2, 2019

Primary Completion

August 30, 2019

Study Completion

September 30, 2019

Last Updated

January 9, 2019

Record last verified: 2018-12